Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: A systematic review

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Seifert, Marva ^a   Catanzaro, Donald ^a   Catanzaro, Antonino ^a   Rodwell, Timothy C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; GLYCINE; ISOLEUCINE; ISONIAZID; THREONINE; BACTERIAL PROTEIN; INHA PROTEIN, MYCOBACTERIUM; OXIDOREDUCTASE; TUBERCULOSTATIC AGENT;

APHC OXYR GENE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; DNA SEQUENCE; EFPA GENE; FABG1 INHA GENE; FADE24 GENE; FURA KATG GENE; GENE FREQUENCY; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; HUMAN; INHA 15 GENE; INIA GENE; INIB GENE; INIC GENE; KASA GENE; KATG315 GENE; MYCOBACTERIUM TUBERCULOSIS; NAT GENE; NDH GENE; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; PROMOTER REGION; RV0340 GENE; RV1592C GENE; RV1772 GENE; SRMR GENE; SYSTEMATIC REVIEW; TUBERCULOSIS; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATION;

MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ISONIAZID; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84925746153     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119628     Document Type: Article

References (43)

1. World Health Organization. Global Tuberculosis Report. Geneva, Switzerland; WHO press. 2013.
2. World Health Organization. Multidrug and Extensively Drug-Resistant TB 2010 Global Report of Surveillance and Response. Geneva, Switzerland; WHO press. 2010. PMID: 21141336
3. Sougakoff W. Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis. Clin Microbiol Infect. 2011; 17: 800-805. doi: 10.1111/j.1469-0691.2011.03577.x PMID: 21682800
4. Middlebrook G. Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report. Am RevTuberc. 1954; 69: 471-472. PMID: 13138881
5. Mitchison DA. The diagnosis and therapy of tuberculosis during the past 100 years. Am J RespirCrit Care Med. 2005; 171:699-706. PMID: 15709048
6. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2009; 13:1320-1330. PMID: 19861002
7. World Health Organization. Global Tuberculosis Report. Geneva, Switzerland; WHO Press. 2012.
8. Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoSOne. 2011; 6: e17601. doi: 10.1371/journal.pone.0017601 PMID: 21483732
9. Hoek KG, Van Rie A, van Helden PD, Warren RM, Victor TC. Detecting drug-resistant tuberculosis: the importance of rapid testing. Mol DiagnTher. 2011; 15:189-194. doi: 10.2165/11593780-000000000-00000 PMID: 21913741
10. Urbanczik R, Rieder HL. Scaling up tuberculosis culture services: a precautionary note. Int J Tuberc Lung Dis. 2009; 13: 799-800. PMID: 19555526
11. World Health Organization. Treatment of tuberculosis: guidlines-4th ed. Geneva Switzerland; WHO Press. 2010.
12. Neonakis IK, Gitti Z, Krambovitis E., Spandidos DA. Molecular diagnostic tools in mycobacteriology. J Microbiol Methods. 2008; 75:1-11. doi: 10.1016/j.mimet.2008.05.023 PMID: 18599139
13. Alcaide F, Coll P. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance. Enferm Infecc Microbiol Clin. 2011; 29 Suppl 1: 34-40. doi: 10.1016/S0213-005X(11)70016-7 PMID: 21420565
14. O'Grady J., Maeurer M, Mwaba P., Kapata N, Bates M, Hoelscher M., et al. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. CurrOpin Pulm Med. 2011; 17:134-141. doi: 10.1097/MCP.0b013e3283452346 PMID: 21415753
15. Lessells RJ, Cooke GS, Newell M.L., Godfrey-Faussett P. Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact. J Infect Dis. 2011; 204 Suppl 4: S1187-1195. doi: 10.1093/infdis/jir412 PMID: 21996701
16. Scior T, Meneses Morales I, Garces Eisele SJ, Domeyer D, Laufer S. Antitubercular isoniazid and drug resistance of Mycobacterium tuberculosis-a review. Arch Pharm (Weinheim). 2002; 335: 511-525. PMID: 12596216
17. Laurenzo D, Mousa SA. Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing. Acta Trop. 2011; 119: 5-10. doi: 10.1016/j.actatropica.2011. 04.008 PMID: 21515239
18. Riska PF, Jacobs WR Jr., Alland D. Molecular determinants of drug resistance in tuberculosis. Int J Tuberc Lung Dis. 2000; 4: S4-10. PMID: 10688142
19. Rattan A, Kalia A, Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis. 1998; 4:195-209. PMID: 9621190
20. Rossetti ML, Valim AR, Silva M.S., Rodrigues VS. [Resistant tuberculosis: a molecular review]. Rev Saude Publica. 2002; 36: 525-532. PMID: 12364929
21. Zhang Y, Heym B, Allen B., Young D, Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature. 1992; 358:591-593. PMID: 1501713
22. Vilcheze C, Wang F, Arai M., Hazbon MH, Colangeli R, Kremer L, et al. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat Med. 2006; 12:1027-1029. PMID: 16906155
23. Banerjee A, Dubnau E, Quemard A., Balasubramanian V, Um KS, Wilson T, et al. inh A, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science. 1994; 263: 227-230. PMID: 8284673
24. Telenti A, Imboden P, Marchesi F., Lowrie D, Cole S, Colston M.J., et al. Detection of rifampicin-resis-tance mutations in Mycobacterium tuberculosis. Lancet. 1993; 341: 647-650. PMID: 8095569
25. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis. 1998; 79: 3-29. PMID: 10645439
26. Ahmad S, Mokaddas E. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. RespirMed. 2009; 103:1777-1790. doi: 10.1016/j.rmed.2009.07.010 PMID: 19660927
27. Sreevatsan S, Pan X, Zhang Y., Deretic V, Musser JM. Analysis of the oxyR-ahpC region in isoniazid-resistant and-susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob Agents Chemother. 1997; 41: 600-606. PMID: 9056000
28. Abate G, Hoffner SE, Thomsen V.O., Miorner H. Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in kat G. Eur J Clin Microbiol Infect Dis. 2001; 20: 329-333. PMID: 11453593
29. Haas WH, Schilke K, Brand J., Amthor B, Weyer K, Fourie P.B., et al. Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob Agents Chemother. 1997; 41:1601-1603. PMID: 9210694
30. Baker LV, Brown TJ, Maxwell O, Gibson A.L., Fang Z., Yates MD, et al. Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC-46A polymorphism. Antimicrob Agents Chemother. 2005; 49:1455-1464. PMID: 15793126
31. National Library of Medicine website. Basic Local Alignment Search Tool. Available: http://blast.ncbi.nlm.nih.gov/Blast.cgi. Accessed: 2015 Feb 13.
32. Georghiou SB, Magana M, Garfein R.S., Catanzaro DG, Catanzaro A, Rodwell TC. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreo-mycin: a systematic review. PLoS One. 2012; 7: e33275. doi: 10.1371/journal.pone.0033275 PMID: 22479378
33. World Health Organization website. World Health Organization Regional Offices. Available: http://www.who.int/about/regions/en/. Accessed: 2013 Feb 13.
34. Lin SY, Probert W, Lo M., Desmond E. Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J Clin Microbiol. 2004; 42: 4204-4208. PMID: 15365012
35. Campbell PJ, Morlock GP, Sikes R.D., Dalton TL, Metchock B, Starks AM, et al. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2011; 55: 2032-2041. doi: 10.1128/AAC.01550-10 PMID: 21300839
36. Rodwell TC, Valafar F, Douglas J., Qian L, Garfein RS, Chawla A, et al. Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. J Clin Microbiol. 2014; 52: 781-789. doi: 10.1128/JCM.02701-13 PMID: 24353002
37. Jenkins HE, Zignol M, Cohen T. Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009. PLoSOne. 2011; 6: e22927. doi: 10.1371/journal.pone.0022927 PMID: 21829557
38. Abal AT, Ahmad S, Mokaddas E. Variations in the occurrence of the S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Microb Drug Resist. 2002; 8: 99-105. PMID: 12118524
39. Chikamatsu K, Mizuno K, Aono A., Yamada H, Sugamoto T, Nishiyama H., et al. [Evaluation of Geno-Type MTBDRplus for the detection of multi-drug-resistant Mycobacterium tuberculosis strains]. Kek-kaku. 2011; 86: 697-702. PMID: 21922778
40. Cohen T, Becerra MC, Murray MB. Isoniazid resistance and the future of drug-resistant tuberculosis. Microb Drug Resist. 2004; 10: 280-285. PMID: 15650371
41. Ando H, Kondo Y, Suetake T., Toyota E, Kato S, Mori T., et al. Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2010; 54:1793-1799. doi: 10.1128/AAC.01691-09 PMID: 20211896
42. Lin SY, Rodwell TC, Victor T.C., Rider EC, Pham L, Catanzaro A, et al. Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens. J Clin Microbiol. 2014; 52: 475-482. doi: 10.1128/JCM.01821-13 PMID: 24478476
43. Gagneux S, Burgos MV, DeRiemer K, Encisco A., Munoz S, Hopewell PC, et al. Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog. 2006; 2: e61. PMID: 16789833